| Франція | Туреччина | Україна | |
| Плазмаферез | від $1,800 | від $1,200 | від $700 |
| Внутрішньовенна терапія куркуміном | від $750 | від $350 | від $400 |
| Інфузія донорської пуповинної крові | від $11,000 | від $5,000 | від $3,000 |
| Терапевтичний аферез | - | від $1,350 | - |
| Селективний аферез | - | від $1,550 | - |
Ви не сплачуєте за послуги Bookimed. Ціни на лікування імунології відповідають прайс-листу клініки. Ви сплачуєте безпосередньо в клініці. Доступна оплата частинами.
Bookimed піклується про вашу безпеку. Ми співпрацюємо лише з медичними закладами, які дотримуються високих міжнародних стандартів у галузі імунології та мають необхідні ліцензії для обслуговування пацієнтів з різних країн.
Bookimed надає безкоштовну експертну підтримку. Особистий лікар-координатор супроводжує вас до, під час та після лікування, вирішуючи будь-які питання. Ви ніколи не залишитеся наодинці, проходячи імунологічні процедури в іншій країні.
France treats autoimmune diseases through a network of university hospitals (CHU) and certified reference centers. The national FAI2R network coordinates over 80 expert sites. Leading facilities include Hôpital Cochin and Hôpital Pitié-Salpêtrière in Paris, alongside specialized interdisciplinary hubs in Montpellier and Lyon.
Bookimed Expert Insight: French university hospitals prioritize interdisciplinary care for rare conditions. Data shows specialized centers in Montpellier, like the Immun4Cure institute, integrate research directly into clinical practice. Patients benefit from these academic environments where specialists manage complex diagnostics alongside active clinical trials.
Patient Consensus: Patients recommend using hospital-based care over private clinics for better insurance coverage. They suggest bringing complete medical records to ensure specialists can provide an effective treatment plan.
France manages advanced immunotherapies through a centralized, state-regulated framework. The Haute Autorité de Santé (HAS) provides early access to CAR-T therapies via the AAP system. This mechanism bypasses standard pricing delays for urgent hematological cases. Highly specialized, certified academic centers handle all clinical administration.
Bookimed Expert Insight: French immunology centers utilize a decentralized preparatory model to optimize resource use. While academic hubs handle complex cell engineering, regional partners often manage initial chemotherapy steps. This integration between public labs and regional hospitals maintains high patient volumes without overloading specialized beds.
Patient Consensus: These therapies require intensive hospital stays in large tertiary centers due to potential side effects. Patients note that staying near the facility is vital for monitoring after the infusion process.
France manages CIDP and immune deficiencies through standardized national protocols called PNDS. Treatment utilizes intravenous or subcutaneous immunoglobulins to prevent nerve damage and infections. The national health system typically covers these essential therapies. Specialized hospital reference centers oversee prescription safety and product traceability.
Bookimed Expert Insight: French immunology centers prioritize transitioning stable patients to subcutaneous SCIg therapy. This shift typically reduces hospital visits while maintaining steady IgG serum levels. Our data shows that initial consultations for treatment planning in France range from Ціна за запитом to Ціна за запитом.
Patient Consensus: Patients note that immunoglobulin therapy is a long-term commitment rather than a quick cure. Many emphasize that keeping a strict infusion schedule is vital to prevent weakness from returning between doses.
Allergen immunotherapy is a primary treatment for respiratory allergies and venom hypersensitivity in France. The national health system, Assurance Maladie, routinely covers these desensitization protocols. Specialists favor sublingual methods for safety. Patients typically combine public coverage with private insurance to manage costs.
Bookimed Expert Insight: Immunology consultations in France start from Ціна за запитом. While the system is supportive, international patients should note that reimbursement depends on social security enrollment. Public coverage is not automatic for new arrivals. We recommend bringing detailed records to match specific allergen molecules available locally.
Patient Consensus: Patients note that the public system is very supportive of long-term therapy. However, many emphasize that enrolling in social security is a slow, bureaucratic process for newcomers.